Back to Search
Start Over
Letter: ustekinumab's effectiveness outcomes compared with vedolizumab in Crohn's disease-what about mucosal healing and biomarkers?
- Publication Year :
- 2020
- Subjects :
- Oncology
medicine.medical_specialty
Crohn's disease
Hepatology
business.industry
Tumor Necrosis Factor-alpha
Gastroenterology
MEDLINE
medicine.disease
Antibodies, Monoclonal, Humanized
Vedolizumab
Crohn Disease
Internal medicine
Mucosal healing
Ustekinumab
Monoclonal
medicine
Humans
Pharmacology (medical)
Tumor necrosis factor alpha
business
Biomarkers
medicine.drug
Subjects
Details
- Language :
- English
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....f93937f54006c300916ec211ff29047f